Stockreport

Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity [Yahoo...

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Late-breaking results also published in Arthritis & Rheumatology INDIANAPOLIS March 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detaile [Read more]